Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 240

1.

Pretransplant IgA-Anti-Beta 2 Glycoprotein I Antibodies As a Predictor of Early Graft Thrombosis after Renal Transplantation in the Clinical Practice: A Multicenter and Prospective Study.

Morales JM, Serrano M, Martinez-Flores JA, Gainza FJ, Marcen R, Arias M, Escuin F, Pérez D, Andres A, Martínez MA, Maruri N, Alvarez E, Castañer JL, López-Hoyos M, Serrano A.

Front Immunol. 2018 Mar 12;9:468. doi: 10.3389/fimmu.2018.00468. eCollection 2018.

2.

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients.

Cruzado JM, Lauzurica R, Pascual J, Marcen R, Moreso F, Gutierrez-Dalmau A, Andrés A, Hernández D, Torres A, Beneyto MI, Melilli E, Manonelles A, Arias M, Praga M.

Kidney Int Rep. 2017 Sep 28;3(1):122-132. doi: 10.1016/j.ekir.2017.08.016. eCollection 2018 Jan.

3.

Outcomes of Peritoneal Dialysis Catheter Left In Place after Kidney Transplantation.

Pampa-Saico S, Caravaca-Fontán F, Burguera-Vion V, Nicolás VD, Yerovi-León E, Jimenez-Álvaro S, Fernández-Rodríguez A, Marcén R, Rivera-Gorrín M.

Perit Dial Int. 2017 Nov-Dec;37(6):651-654. doi: 10.3747/pdi.2017.00031.

PMID:
29123003
4.

Preserved Renal Function in Kidney Transplantation over a Thrombosed Aortobifemoral Bypass Graft: The Role of Retrograde Flow and Early Thrombolysis.

Pampa-Saico S, Jiménez-Alvaro S, Caravaca-Fontán F, Fernández-Rodríguez A, Rivera-Gorrín M, Sánchez J, Chinchilla A, Marcén R.

Case Rep Transplant. 2016;2016:6579591. doi: 10.1155/2016/6579591. Epub 2016 Aug 4.

5.

Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study).

Torres A, Torregrosa V, Marcen R, Campistol JM, Arias M, Hernández D, Fernández C, Esforzado N, Paschoalin R, Pérez N, García AI, Del Amo M, Pomés J, González Rinne A, Marrero D, Pérez E, Henríquez F, Díaz JM, Silva I, López V, Perello M, Ramos D, Beneyto I, Cruzado JM, Martínez Castelao A, Bravo J, Rodríguez M, Díaz C, Crespo J, Anaya F, Rodríguez ML, Cubero JJ, Pascual P, Romero R, Andrés Belmonte A, Checa MD, Jiménez C, Escuin F, Crespo M, Mir M, Gómez G, Bayes B, González MJ, Gutiérrez A, Cuberes M, Rodríguez Benoit A, García T, Llamas F, Ortega A, Conde JL, Gómez Alamillo C.

Nefrologia. 2016 May-Jun;36(3):255-67. doi: 10.1016/j.nefro.2016.03.004. Epub 2016 Apr 28. English, Spanish.

6.

Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-year observational results.

Krämer BK, Montagnino G, Krüger B, Margreiter R, Olbricht CJ, Marcen R, Sester U, Kunzendorf U, Dietl KH, Rigotti P, Ronco C, Hörsch S, Banas B, Mühlbacher F, Arias M; European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.

Transpl Int. 2016 Mar;29(3):307-14. doi: 10.1111/tri.12716. Epub 2015 Dec 11.

7.

Bone fractures and lumbar mineral density after renal transplantation. A long-term cross-sectional study.

Jiménez S, Marcén R, Vaamonde C, Caballero C, Fernández-Rodríguez A, Villafruela JJ, Galeano C, Teruel JL, Quereda C.

Clin Transplant. 2016 Feb;30(2):131-7. doi: 10.1111/ctr.12666.

PMID:
26546290
8.

Black esophagus in the early kidney post-transplant period.

Caravaca-Fontán F, Jimenez S, Fernández-Rodríguez A, Marcén R, Quereda C.

Clin Kidney J. 2014 Dec;7(6):613-4. doi: 10.1093/ckj/sfu094. Epub 2014 Sep 14. No abstract available.

9.

Development of urologic de novo malignancies after renal transplantation.

Hevia V, Gómez V, Díez Nicolás V, Alvarez S, Gómez Del Cañizo C, Galeano C, Gomis A, García-Sagredo JM, Marcen R, Burgos FJ.

Transplant Proc. 2014 Jan-Feb;46(1):170-5. doi: 10.1016/j.transproceed.2013.12.004.

PMID:
24507046
10.

Glomerular filtration rate: utility for assessing long-term renal allograft outcomes in kidney allograft recipients.

Marcén R, Dal Canton A.

J Nephrol. 2013 Nov-Dec;26(6):1009-24. doi: 10.5301/jn.5000308. Epub 2013 Nov 26. Review.

PMID:
24284526
11.

Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation?

Marcén R, Jimenez S, Fernández-Rodriguez A, Galeano C, Villafruela JJ, Gomis A, Teruel JL, Quereda C.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv47-52. doi: 10.1093/ndt/gfs508.

PMID:
23258811
12.

Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study.

Morales JM, Marcén R, del Castillo D, Andres A, Gonzalez-Molina M, Oppenheimer F, Serón D, Gil-Vernet S, Lampreave I, Gainza FJ, Valdés F, Cabello M, Anaya F, Escuin F, Arias M, Pallardó L, Bustamante J.

Nephrol Dial Transplant. 2012 Dec;27 Suppl 4:iv39-46. doi: 10.1093/ndt/gfs544.

13.

Anemia at 1 year after kidney transplantation has a negative long-term impact on graft and patient outcomes.

Marcén R, Galeano C, Fernandez-Rodriguez A, Jiménez S, Teruel JL, Burgos FJ, Quereda C.

Transplant Proc. 2012 Nov;44(9):2593-5. doi: 10.1016/j.transproceed.2012.09.033.

PMID:
23146465
14.

The effects of mineral metabolism markers on renal transplant outcomes.

Marcén R, Jimenez S, Fernández A, Galeano C, Villafruela JJ, Burgos FJ, Quereda C.

Transplant Proc. 2012 Nov;44(9):2567-9. doi: 10.1016/j.transproceed.2012.09.041.

PMID:
23146456
15.

Patients with a failed renal transplant.

Marcén R, Teruel Briones JL.

Minerva Urol Nefrol. 2011 Mar;63(1):35-44. Review.

PMID:
21336244
16.

Utilization of elderly kidney donors (>70 years) does not affect graft survival in the medium term.

Galeano C, Marcén R, Jimenez S, Fernández Rodríguez A, Sosa H, Villafruela JJ, Teruel JL, Burgos FJ, Quereda C.

Transplant Proc. 2010 Dec;42(10):3935-7. doi: 10.1016/j.transproceed.2010.08.069.

PMID:
21168591
17.

[Treatment of uraemic anorexia with megestrol acetate].

Fernández Lucas M, Teruel JL, Burguera V, Sosa H, Rivera M, Rodríguez Palomares JR, Marcén R, Quereda C.

Nefrologia. 2010;30(6):646-52. doi: 10.3265/Nefrologia.pre2010.Aug.10546. Spanish.

18.

Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.

Marcén R, Galeano C, Fernández-Rodriguez A, Jiménez-Alvaro S, Teruel JL, Rivera M, Burgos FJ, Quereda C.

Transplant Proc. 2010 Oct;42(8):3055-7. doi: 10.1016/j.transproceed.2010.08.002.

PMID:
20970609
19.

Cholecalciferol supplements improve vitamin D deficiency in renal transplant recipients.

Jiménez Álvaro S, Marcén R, Villacorta J, Fernández-Rodríguez A, Galeano C, Villafruela JJ, Teruel JL, Burgos FJ, Quereda C.

Transplant Proc. 2010 Oct;42(8):2921-3. doi: 10.1016/j.transproceed.2010.07.067.

PMID:
20970571
20.

Renal transplantation in patients with hepatitis C virus antibody. A long national experience.

Morales JM, Marcén R, Andres A, Domínguez-Gil B, Campistol JM, Gallego R, Gutierrez A, Gentil MA, Oppenheimer F, Samaniego ML, Muñoz-Robles J, Serón D.

NDT Plus. 2010 Jun;3(Suppl_2):ii41-ii46.

Supplemental Content

Loading ...
Support Center